scholarly article | Q13442814 |
P2093 | author name string | Benjamin Dekel | |
Orit Harari-Steinberg | |||
Dorit Omer | |||
Oren Pleniceanu | |||
Einat Azaria | |||
P2860 | cites work | Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells? | Q24672066 |
The tuberous sclerosis complex | Q29619128 | ||
Treatment of renal angiomyolipoma: pooled analysis of individual patient data | Q31034245 | ||
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis | Q34009330 | ||
Angiomyolipoma Have Common Mutations in TSC2 but No Other Common Genetic Events | Q34031604 | ||
Perivascular epithelioid cell neoplasms: pathology and pathogenesis | Q34992388 | ||
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms | Q35746972 | ||
Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms | Q37292937 | ||
PPARG is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target | Q37734001 | ||
Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy | Q38732059 | ||
Challenge of FNA diagnosis of angiomyolipoma: A study of 33 cases | Q52915023 | ||
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial | Q55981839 | ||
Renal epithelioid angiomyolipoma with malignant features: Histological evaluation and novel immunohistochemical findings | Q87606946 | ||
P433 | issue | 1 | |
P304 | page(s) | 155-159 | |
P577 | publication date | 2017-08-12 | |
P1433 | published in | KI reports | Q27727507 |
P1476 | title | mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma | |
P478 | volume | 3 |